| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA809: Imlifidase for desensitisation treatment before kidney transplant in people with chronic kidney disease |
|
Medicine details |
|
| Medicine name | imlifidase (Idefirix®) |
| Formulation | oral formulation |
| Reference number | 4170 |
| Indication | Desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor |
| Company | Hansa Biopharma |
| BNF chapter | Malignant disease & immunosuppression |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 07/09/2020 |
| NICE guidance | |